ENOV - Enovis to acquire Novastep strengthening position in global foot and ankle market
2023-04-03 07:21:21 ET
- Enovis ( NYSE: ENOV ) announced a definitive agreement to acquire Novastep, a subsidiary of Amplitude Surgical, and global developer of clinically proven foot and ankle solutions.
- The transaction is expected to close in Q2 of 2023.
- A leading player in Minimally Invasive Surgery foot and ankle solutions, Novastep reported ~$20M in annual revenues.
- Novastep’s portfolio of CE marked forefoot and midfoot implants and strong OUS channel will further strengthen Enovis’ global position in the $3B+ global foot and ankle market.
For further details see:
Enovis to acquire Novastep, strengthening position in global foot and ankle market